Simply Wall St.
Pharming Group (ENXTAM:PHARM) Valuation After FDA Complete Response Letter On Joenja Pediatric Filing
➖
AI Sentiment
Neutral
4/10
Pharming Group N.V. News
Latest updates and market news for PHAR
7 news
Jan 30 - Feb 5, 2026
Page 1
MarketBeat
Pharming Group Investor Day: 2026 revenue outlook tops Street as Joenja growth, readouts loom
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Pharming Group Issues 2026 Revenue Guidance; Shares Up Pre-Bell
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
📈
AI Sentiment
Highly Positive
9/10
Investor's Business Daily
Why Pharming, A Top 3% Biotech Stock, Just Took A Double-Digit Beating
MT Newswires
Wall Street Set to Open Lower Monday as Investors Await Major Tech Earnings
➖
AI Sentiment
Neutral
4/10
GlobeNewswire
Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS
📉
AI Sentiment
Negative
3/10
Share this news page